,
your personalized virtual assistant to find clinical trials. Go head, 
James Levine, MD
Beth Israel Deaconess Medical CenterBoston, Massachusetts - 02215 |
- CLINICAL TRIALS 5
- CONDITIONS15
- INTERVENTIONS10
- SINCE2004
RAD001 in Combination With PKC412 in Patients With Relapsed Refractory or Poor Prognosis AML or MDS
January 2009 - January 2011
Reduced Intensity Conditioning With Clofarabine Antithymocyte Globulin (ATG) Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
June 2008 - June 2011
Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
October 2004 - June 2011
Bortezomib Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
August 2006 - August 2010
Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
April 2005 - September 2011
Lymphoma
Lymphoma, Non-Hodgkin
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Carcinoma, Renal Cell
Kidney Neoplasms
Hodgkin Disease
Lenalidomide
Rad001
Bortezomib
Dexamethasone
Clofarabine
Antithymocyte Globulin
Pkc412
Dendritic Cell Tumor Fusion Vaccine
Granulocyte Macrophage Colony Stimulating Factor (Gm-Csf)
Dendritic Cell Tumor Fusion
